Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Poland

Marie Skłodowska-Curie Action · Running

SAFE-DADA Molecular Science Against Falsified Drugs and Drug Hazards

Coordinator
Uniwersytet Warminsko Mazurski W Olsztynie, Poland
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€1.7m
Total cost
—
Partners
21 organisations in 12 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101344557

What the project is doing

In the project's own words, from its summary on CORDIS.

SAFE-DADA proposes a comprehensive strategy for identifying falsified and substandard medicines by leveraging Nuclear Magnetic Resonance (NMR) relaxation and Nuclear Quadrupole Resonance (NQR) techniques. This approach transcends conventional methodsthat focus primarily on the composition and structure of pharmaceutical products, aiming instead at the innovative concept to characterize molecular dynamics and detect even subtle variations in molecular arrangement and interactions.

In parallel, the projectseeks to reveal and exploit synergies among a broad spectrum of complementary analytical techniques, including Chromatography, Mass Spectrometry, Photochemistry, Vibrational spectroscopy, Broadband Acoustic Resonance Dissolution Spectroscopy, and IsotopeRatio Mass Spectrometry, to integrate their strengths against the increasingly sophisticated routes of drug falsification. The ultimate concept rests on two complementary pillars, NMR-based and non-NMR methods, together to develop fast, reliable, and portablestrategies for drug authentication.

These objectives bring together experts from academia and industry, encompassing multidisciplinary expertise in physics, chemistry, pharmacology, life sciences, and engineering. The concerted effort spans not only a diverse range of molecular science approaches but also a broad array of pharmaceutical products, including antibiotics, oncological, antimicrobial, and antimalarial drugs, as well as antihistamines, antitussives, and herbal medicines.

The project also emphasizes knowledge exchange, offering extensive training for early-career researchers, not only to become experts in pharmaceutical analysis and drug authentication, but also to develop the unique ability to integrate and exploit synergies among diverse molecular science methods for a wide range of applications. Furthermore, SAFE-DADA raises public awareness, highlighting the scale and dangers of drug falsification.

Who is involved

OrganisationCityCountryRole
Uniwersytet Warminsko Mazurski W OlsztynieOlsztynPolandCoordinator
Universidade Federal Do Rio De JaneiroRio De JaneiroBrazilAssociatedpartner
Colegio Mayor De Nuestra Senora Delrosario Corporacion Sin Animo De LucroBogota DcCOAssociatedpartner
Productos Roche SABogotaCOAssociatedpartner
Martin-Luther-Universitat Halle-WittenbergHalleGermanyParticipant
Resonance Systems GmbHKirchheim Unter TeckGermanyParticipant
University College Cork - National University of Ireland, CorkCorkIrelandParticipant
Stelar SRLMedeItalyParticipant
Universita Degli Studi Del Piemonte Orientale Amedeo AvogadroVercelliItalyParticipant
Universita Degli Studi Di PaviaPaviaItalyParticipant
Jomo Kenyatta University of Agriculture and TechnologyNairobiKenyaAssociatedpartner
University of NairobiNairobiKenyaAssociatedpartner
Viva Healthcare LimitedNairobiKenyaAssociatedpartner
Universiti Kebangsaan MalaysiaSelangor Darul EhsanMYAssociatedpartner
National University of Sciences Andtechnology at IslamabadIslamabadPKAssociatedpartner
Seraph PharmaceuticalIslamabadPKAssociatedpartner
Uniwersytet Im. Adama Mickiewicza WpoznaniuPoznanPolandParticipant
Institutul National De Cercetare-Dezvoltare Pentru Tehnologii Izotopice Si Moleculare-Incdtim Cluj-NapocaCluj - NapocaRomaniaParticipant
Middle East Technical UniversityAnkaraTürkiyeParticipant
Wellnessbiotics Saglikli Yasam Ve Modern Dogal Gida Takviyeleri Uretim Ve Ticaret Anonim SirketiAksarayTürkiyeParticipant
Muhimbili University of Health and Allied SciencesDar Es SalaamTZAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI